FDA

Jul 2, 2024 04:06PM

Jul 2, 2024 04:05PM

Jul 2, 2024 01:55PM

Jul 2, 2024 01:36PM

Jul 2, 2024 09:07AM

Jul 2, 2024 09:06AM

Jul 2, 2024 08:33AM Vertex Pharma (VRTX) Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for CF

Jul 2, 2024 08:32AM

Jul 2, 2024 08:30AM

Jul 2, 2024 08:24AM

Jul 2, 2024 08:04AM

Jul 2, 2024 08:00AM

Jul 2, 2024 07:55AM

Jul 2, 2024 07:32AM Cognition Therapeutics (CGTX): Results from Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease Accepted for Presentation at AAIC

Jul 2, 2024 07:31AM

Jul 2, 2024 07:30AM

Jul 2, 2024 07:30AM

Jul 2, 2024 07:00AM

Jul 2, 2024 06:32AM

Jul 2, 2024 06:30AM

Jul 1, 2024 04:31PM HOOKIPA Pharma (HOOK) Doses First Person in Phase 1b Clinical Trial of HB-500

Jul 1, 2024 04:06PM

Jul 1, 2024 09:01AM

Jul 1, 2024 08:35AM

Jul 1, 2024 08:30AM

Jul 1, 2024 08:15AM

Jul 1, 2024 08:07AM

Jul 1, 2024 08:05AM Humacyte (HUMA) Acellular Tissue Engineered Vessel Receives FDA’s RMAT Designation for Patients with Advanced PAD

Jul 1, 2024 08:02AM

Jul 1, 2024 08:00AM

Jul 1, 2024 07:30AM

Jul 1, 2024 06:31AM

Jul 1, 2024 06:00AM

Jun 28, 2024 11:31AM

Jun 28, 2024 11:30AM Johnson & Johnson (JNJ) reports positive results from the nipocalimab Phase 3 Vivacity-MG3 study

Jun 28, 2024 11:08AM

Jun 28, 2024 08:32AM

Jun 28, 2024 08:07AM

Jun 28, 2024 08:01AM

Jun 28, 2024 08:01AM

Jun 28, 2024 07:56AM

Jun 28, 2024 07:28AM Rocket Pharmaceuticals (RCKT) Provides Regulatory Update on KRESLADI

Jun 28, 2024 07:17AM

Jun 28, 2024 07:17AM

Jun 28, 2024 07:02AM

Jun 28, 2024 07:01AM

Jun 28, 2024 07:00AM

Jun 28, 2024 06:59AM

Jun 28, 2024 06:30AM ARS Pharmaceuticals (SPRY) Announces EURneffy Recommended for Approval by CHMP

Jun 28, 2024 06:00AM

67,608 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.